Evidence map›Paper›PMID 19920172›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

The anti-apoptotic protein HAX-1 is a regulator of cardiac function.

Wen Zhao, Jason R Waggoner, Zhi-Guo Zhang, Chi Keung Lam, Peidong Han, Jiang Qian, Paul M Schroder, Bryan Mitton, Aikaterini Kontrogianni-Konstantopoulos, Seth L Robia and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Intrinsically disordered HAX-1 regulates CaBiochimica et biophysica acta. Biomembranes · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. HAX-1 regulates SERCA2a oxidation and degradation.Journal of molecular and cellular cardiology · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Wen ZhaoDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575, USA.
Jason R Waggoner
Zhi-Guo Zhang
Chi Keung Lam
Peidong Han
Jiang Qian
Paul M Schroder
Bryan Mitton
Aikaterini Kontrogianni-Konstantopoulos
Seth L Robia
Evangelia G Kranias
University of Cincinnati Medical Center · USLoyola University Chicago · USUniversity of Maryland, Baltimore · US

Funding

PKCa Signaling Regulates Contractility and Heart FailureP50HL077101 · NHLBI · UNIVERSITY OF CINCINNATI · PI DORN, GERALD W. · 2005 to 2009
$19.1M
Structural Determinants of Calcium Pump RegulationR01HL092321 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI Seth L Robia · 2008 to 2026
$8.9M
Cardiac Sarcoplasmic Reticulum Calcium Cycling ProteinsR01HL064018 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 2000 to 2017
$6.8M
TARGETED ABLATION AND ALTERATION OF MOUSE PHOSPHOLAMBANR01HL026057 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 1985 to 2017
$5.3M
Structure Changes of Ion-motive ATPasesR01HL106189 · NHLBI · LOYOLA UNIVERSITY CHICAGO · PI ROBIA, SETH L · 2011 to 2014
$1.5M
TARGETED ABLATION AND ALTERATION OF PHOSPHOLAMBANR37HL026057 · NHLBI · UNIVERSITY OF CINCINNATI · PI KRANIAS, EVANGELIA G · 1994 to 2003
$1.1M
Novel Physical Methods for Determining Membrane Protein Dynamics and KineticsK01EB006061 · NIBIB · LOYOLA UNIVERSITY CHICAGO · PI ROBIA, SETH L · 2007 to 2011
$772k
NHLBI NIH HHS HL-26057NHLBI NIH HHS HL-64018NHLBI NIH HHS HL-77101NHLBI NIH HHS P50 HL077101NHLBI NIH HHS R01 HL026057NHLBI NIH HHS R01 HL064018NHLBI NIH HHS R01 HL092321NHLBI NIH HHS R01 HL106189NHLBI NIH HHS R37 HL026057NIBIB NIH HHS K01 EB006061
6 · The paper itself

Abstract

The HS-1 associated protein X-1 (HAX-1) is a ubiquitously expressed protein that protects cardiomyocytes from programmed cell death. Here we identify HAX-1 as a regulator of contractility and calcium cycling in the heart. HAX-1 overexpression reduced sarcoplasmic reticulum Ca-ATPase (SERCA2) pump activity in isolated cardiomyocytes and in vivo, leading to depressed myocyte calcium kinetics and mechanics. Conversely, downregulation of HAX-1 enhanced calcium cycling and contractility. The inhibitory effects of HAX-1 were abolished upon phosphorylation of phospholamban, which plays a fundamental role in controlling basal contractility and constitutes a key downstream effector of the beta-adrenergic signaling cascade. Mechanistically, HAX-1 promoted formation of phospholamban monomers, the active/inhibitory units of the calcium pump. Indeed, ablation of PLN rescued HAX-1 inhibition of contractility in vivo. Thus, HAX-1 represents a regulatory mechanism in cardiac calcium cycling and its responses to sympathetic stimulation, implicating its importance in calcium homeostasis and cell survival.

Indexed as

ApoptosisHeart Function TestsAgingAnimalsBiological TransportCalciumCalcium-Binding ProteinsDown-RegulationFluorescence Resonance Energy TransferHeartIntracellular Signaling Peptides and ProteinsMiceMice, TransgenicMyocardial ContractionMyocytes, CardiacOrgan SpecificityCalciumCalcium-Binding ProteinsHs1bp1 protein, mouseIntracellular Signaling Peptides and ProteinsPhospholambanProteinsSarcoplasmic Reticulum Calcium-Transporting ATPases

Identifiers

PMID19920172
PMCPMC2791603
OpenAlexW1975322691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.